Global Perphenazine Market by Manufacturers, Regions, Type and Application, Forecast to 2025 By Innovation Market Research, Inc

 Pulichser: XYZResearch

May 2020

 Pages: 106

 IMR 6998

In this report,perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.

In the last several years, Global market of Perphenazine developed slowly, with an average growth rate of 0.4%. In 2017, Global Revenue of Perphenazine is 95.46 M USD; the actual sales are about 12750 K Unit.

Perphenazine can be divided into two categories - oral forms type and injectable solution type. Oral forms’ sales market share accounted for the highest proportion, with a figure of 98.17% in 2017, food grade account for 1.83%.

The global average price of Perphenazine is in the increasing trend, from 6.95 USD/Unit in 2012 to 7.08 USD/Unit in 2016. With the situation of global economy, prices will still be in increasing trend in the following five years.

Innovation Market Research center data shows that United States is the biggest contributor to the Perphenazine revenue market, accounted for 45.89% of the total global market with a revenue of 41.66 million USD in 2016, followed by Europe, 15.62% with a revenue of 14.18 million USD.

Teva is the largest company in the global Perphenazine market, accounted for 46.38% of the revenue market share in 2017, followed by Sandoz and Endo, accounted for 18.82% and 13.23% of the revenue market share in 2017.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Perphenazine in these regions, from 2014 to 2026 (forecast), covering
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Global Perphenazine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Teva
Sandoz
Endo
Mylan
ZHPHARMA
Shandong Boshan Pharma

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Oral Forms
Injectable Solution

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Perphenazine for each application, including
Psychosis
Antiemetic

If you have any special requirements, please let us know and we will offer you the report as you want.

Please fill in the form below to Request for Customized Report
91
  
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

  
Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

Purchase Options





Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities

Customize

  • We offer 20% free customization on every purchase.

Get in touch!

  +91 810 895 3541


  info@innovationmarketresearch.com